GlassScriptPhysician profile
Jeffrey D Diller
NPI 1245473289
$10,168.44
in general payments reported to CMS, 2019-2025
16 companies · $1,049 in 2025
The $1,049 reported for 2025 was more than what 88% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $594 · 2022: $3,548 · 2023: $2,395 · 2024: $2,582 · 2025: $1,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,281 · Travel and Lodging: $2,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,280.71 |
| Travel and Lodging | $2,745.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,331.47 | 2021-2025 | Oasis, Versajet, Acticoat 4" X 4" |
| Vericel Corporation | $3,098.00 | 2022 | |
| Kerecis Limited | $2,967.37 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Avita Medical Americas, LLC | $355.58 | 2021-2025 | Recell, Permeaderm, Cohealyx |
| Medline Industries LP | $59.42 | 2025 | |
| Organogenesis INC. | $53.44 | 2024-2025 | Puraply Wound Matrix |
| Kci USA, INC. | $47.37 | 2021-2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
| Urgo Medical North America, LLC | $43.18 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Integra Lifesciences Corporation | $40.56 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mimedx Group, INC. | $36.64 | 2025 | |
| Baxter Healthcare | $29.26 | 2022-2023 | Artiss |
| Hydrofera LLC | $28.67 | 2021-2022 | |
| Sanara Medtech INC. | $23.35 | 2024 | Celleraterx |
| Reprise Biomedical, INC. | $18.45 | 2024 | Miro3d |
| Paratek Pharmaceuticals, INC. | $18.22 | 2025 | Nuzyra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $17.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Diller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.